WallStSmart
MGX

Metagenomi, Inc. Common Stock

NASDAQ: MGX · HEALTHCARE · BIOTECHNOLOGY

$1.38
+2.22% today

Updated 2026-04-30

Market cap
$55.68M
P/E ratio
P/S ratio
2.21x
EPS (TTM)
$-2.36
Dividend yield
52W range
$1 – $4
Volume
0.2M

WallStSmart proprietary scores

29
out of 100
Grade: F
Strong Sell
Investment rating
4.7
Growth
C
5.0
Quality
C+
2.5
Profitability
F
6.7
Valuation
B
/9
Piotroski F-Score
Altman Z-Score
Industry rank
View all highly rated stocks (75+) →202 stocks currently score above 75

Price targets

Analyst target
$9.33
+576.09%
12-Month target
Intrinsic (DCF)
$2.87
Margin of safety
+47.04%
0 Strong Buy4 Buy1 Hold0 Sell0 Strong Sell

Price chart

X-Ray snapshot

Strengths
+ 47.04% below intrinsic value
Risks
- Thin margins at 0.00%
- Negative free cash flow $-23.63M
- Revenue declining -59.30% QoQ

Key financials

Revenue Net Income Free Cash Flow
Metric2022202320242025TTM
Revenue$17.20M$44.76M$52.30M$25.21M$25.21M
Net income$-43.59M$-68.25M$-78.06M$-87.87M$-22.53M
EPS$-2.36
Free cash flow$15.75M$-101.22M$-112.19M$-89.47M$-23.63M
Profit margin-253.45%-152.50%-149.26%-348.54%

Peer comparison

CompanyMkt CapScoreGrowthProfitValueQualityMoSRating
MGX$55.68M294.72.56.75.0+47.04%Avoid
LLY$760.43B7810.010.05.06.5Strong Buy
JNJ$547.28B594.79.03.36.0-43.54%Buy
ABBV$360.63B634.08.04.75.0-29.31%Buy
UNH$322.34B545.35.57.34.8+42.06%Buy
AZN$294.17B646.78.05.35.0+4.07%Buy

Smart narrative

Metagenomi, Inc. Common Stock trades at $1.38. Our Smart Value Score of 29/100 indicates the stock is weak. TTM revenue stands at $25.21M. Our DCF model estimates intrinsic value at $2.87.

Frequently asked questions

What is Metagenomi, Inc. Common Stock's stock price?
Metagenomi, Inc. Common Stock (MGX) trades at $1.38.
Is Metagenomi, Inc. Common Stock overvalued?
Smart Value Score 29/100 (Grade F, Strong Sell). DCF value $2.87.
What is the price target of Metagenomi, Inc. Common Stock (MGX)?
The analyst target price is $9.33, representing +576.1% upside from the current price of $1.38.
What is the intrinsic value of Metagenomi, Inc. Common Stock (MGX)?
Based on our DCF model, intrinsic value is $2.87, a +47.0% margin of safety versus $1.38.
What is Metagenomi, Inc. Common Stock's revenue?
TTM revenue is $25.21M.

Company info

SectorHEALTHCARE
IndustryBIOTECHNOLOGY
CountryUSA
ExchangeNASDAQ
CurrencyUSD

Quick metrics

P/S ratio2.21x
ROE-44.70%
Beta0.57
50D MA$1.46
200D MA$1.88
Shares out0.04B
Float0.03B
Short ratio
Avg volume0.2M

Performance

1 week
1 month
3 months
YTD
1 year
3 years
5 years